Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

  1. Coghill, D.R.
  2. Banaschewski, T.
  3. Nagy, P.
  4. Otero, I.H.
  5. Soutullo, C.
  6. Yan, B.
  7. Caballero, B.
  8. Zuddas, A.
Aldizkaria:
CNS Drugs

ISSN: 1179-1934,  1172-7047

Argitalpen urtea: 2017

Alea: 31

Zenbakia: 7

Orrialdeak: 625-638

Mota: Artikulua

DOI: 10.1007/S40263-017-0443-Y GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus